FTSE 100
8.105,32
PKT
-93,79
PKT
-1,14
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 08.11.24 | International Consolidated Airlines Neutral | UBS AG | |
| 08.11.24 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 08.11.24 | BP Underweight | JP Morgan Chase & Co. | |
| 08.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 08.11.24 | RELX Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 07.11.24 | National Grid Buy | UBS AG | |
| 07.11.24 | Rolls-Royce Buy | UBS AG | |
| 07.11.24 | National Grid Outperform | RBC Capital Markets | |
| 07.11.24 | AstraZeneca Sell | UBS AG | |
| 07.11.24 | National Grid Buy | Goldman Sachs Group Inc. | |
| 07.11.24 | National Grid Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 06.11.24 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 06.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 05.11.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 05.11.24 | easyJet Overweight | Morgan Stanley | |
| 05.11.24 | International Consolidated Airlines Overweight | Morgan Stanley | |
| 05.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.11.24 | BP Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.11.24 | AstraZeneca Sell | UBS AG | |
| 04.11.24 | Unilever Halten | DZ BANK | |
| 04.11.24 | Shell (ex Royal Dutch Shell) Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.11.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 04.11.24 | Rolls-Royce Buy | Goldman Sachs Group Inc. | |
| 04.11.24 | Rolls-Royce Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.11.24 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 01.11.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 01.11.24 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 01.11.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Buy | Goldman Sachs Group Inc. | |
| 01.11.24 | GSK Neutral | Goldman Sachs Group Inc. | |
| 01.11.24 | Shell (ex Royal Dutch Shell) Overweight | JP Morgan Chase & Co. | |
| 01.11.24 | RELX Buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.